Help unlock answers we need to fight ALS and Parkinson's
PatientsLikeMe, in partnership with Denali Pharmaceuticals, is conducting a pilot study to evaluate the biological signatures of ALS and Parkinson's and to support the development of a potential new treatment for neurodegeneration.
This study is different than others you may have read about or participated in. It’s focused on comparing ALS and Parkinson's to other conditions, not just controls. And it will use new approaches to connect biomarkers in your blood with your experience with disease, potentially revealing more about how diseases develop in the body.
10,000+ ALS patients and 15,000+ Parkinson's patients have joined our free website to share their health data and track their progress. Now they’re poised to collaborate on a new journey of discovery. Join us and together we'll help unlock new answers in our understanding of these diseases. Because the more we know, the more we can do to fight them.
We are no longer enrolling Parkinson's patients in this study.
Start here, start today
If you are eligible, our phlebotomy partners will reach out to you to schedule your first blood draw.